<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>The optimal management of locally advanced rectal cancer (LARC) often presents a therapeutic challenge. Balancing the benefits of treatment against toxicities and reducing the risk for local and distal recurrences are the mainstay of therapeutic approaches. Recently, several studies have compared a more aggressive approach of delivering several cycles of systemic chemotherapy to the established standard of combined chemoradiation. This approach is termed total neoadjuvant therapy and appears to be beneficial, at least for a subset of patients. The results of the main Phase III studies along with their variations in study design are hereby discussed with the goal of extracting useful clinical suggestions for treatment.</p>
</abstract>

The optimal management of locally advanced rectal cancer (LARC) often presents a therapeutic challenge. Balancing the benefits of treatment against toxicities and reducing the risk for local and distal recurrences are the mainstay of therapeutic approaches. Recently, several studies have compared a more aggressive approach of delivering several cycles of systemic chemotherapy to the established standard of combined chemoradiation. This approach is termed total neoadjuvant therapy and appears to be beneficial, at least for a subset of patients. The results of the main Phase III studies along with their variations in study design are hereby discussed with the goal of extracting useful clinical suggestions for treatment.

Total neoadjuvant therapy in rectal cancer: a review across studies

Forum of Clinical Oncology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"Total neoadjuvant therapy in rectal cancer: a review across studies"}

The optimal management of locally advanced rectal cancer (LARC) often presents a therapeutic challenge. Balancing the benefits of treatment against toxicities...

Total neoadjuvant therapy in rectal cancer: a review across studies

Article Category: Research Article

Publié en ligne: 25 avr. 2024

Pages: -

Reçu: 26 oct. 2023

Accepté: 15 déc. 2023

DOI: https://doi.org/10.2478/fco-2023-0014

Mots clés
rectal cancer, total neoadjuvant therapy, Phase III studies, induction, consolidation, organ preservation

© 2024 Ioannis Gavalas et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Total neoadjuvant therapy in rectal cancer: a review across studies

Article Category: Research Article

Publié en ligne: 25 avr. 2024

Pages: -

Reçu: 26 oct. 2023

Accepté: 15 déc. 2023

DOI: https://doi.org/10.2478/fco-2023-0014

Mots clésrectal cancer, total neoadjuvant therapy, Phase III studies, induction, consolidation, organ preservation

© 2024 Ioannis Gavalas et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mots clés
rectal cancer, total neoadjuvant therapy, Phase III studies, induction, consolidation, organ preservation